NEW YORK (Reuters Health) – Patients with atrial fibrillation undergoing pulmonary vein isolation by radiofrequency catheter ablation are less likely to have immediate recurrence of AF if they’re…
Bonnie Adams, Information Management Coordinator, Schenectady Anesthesia Associates, discusses PECOS, a medicare provider enrollment system that collect information from the CMS-855S (Centers for Medicare & Medicaid Services) enrollment…
Mark Chassin, MD, MPH, MPP, discusses The Joint Commission’s role in health care reform and how physicians can get increased payment for creating “medical homes” or “primary care…
Mark Chassin, MD, MPH, MPP, president of The Joint Commission, discusses how The Joint Commission helps hospitals eliminate complications such as catheter-related bloodstream infections and surgical site infections.…
Mark R. Chassin, MD, MPH, MPP, president of The Joint Commission, discusses Improving America’s Hospitals, the organization’s 2010 annual report on quality and safety. The Joint Commission compiles…
Mark Chassin, MD, MPH, MPP, discusses The Joint Commission Center for Transforming Healthcare, which works with hospitals and systems across the country to come up with more effective…
Mark R. Chassin, MD, MPH, MPP, discusses the changes at The Joint Commission since he became president in 2008. They are working on improved patient outcomes through hospital…
NEW YORK (Reuters Health) – Results of a meta-analysis indicate that anticoagulation may not need to be interrupted in patients undergoing elective coronary angiography. However, the quality of…
NEW YORK (Reuters Health) – For octogenarians undergoing percutaneous coronary intervention, the use of drug-eluting stents is safe and more effective than using bare metal stents, a Dutch…
NEW YORK (Reuters Health) – For patients with multiple myeloma who are not eligible for autologous stem-cell transplantation, a four-drug combination regimen is promising. Adding thalidomide to bortezomib-melphalan-prednisone,…
NEW YORK (Reuters Health) – The GLP-1 receptor agonist exenatide used to treat type 2 diabetes is associated with a lower risk of cardiovascular disease (CVD) events, compared…
NEW YORK (Reuters Health) – Adding the anti-VEGF monoclonal antibody bevacizumab to state-of-the-art adjuvant chemotherapy for stage II or III colon cancer does not improve disease-free survival, according…
